Oncotarget cover image

Press Release: Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer

Oncotarget

CHAPTER

Genomic Alterations Predictive of Poor Clinical Outcomes in Pan-cancer

Exploring the prognostic significance of TP53 mutations, Mute 31 genes, CDK N2A and PTEN deletions, and MYC amplifications in pan-cancer, indicating their independent prediction of poor survival. Results emphasize the importance of tailored treatment strategies for patients with these genomic alterations.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner